Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB.

Aoki T, Kataoka H, Ishibashi R, Nozaki K, Morishita R, Hashimoto N.

Arterioscler Thromb Vasc Biol. 2009 Jul;29(7):1080-6. doi: 10.1161/ATVBAHA.108.180760. Epub 2009 Apr 9.

2.

Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway.

Aoki T, Kataoka H, Ishibashi R, Nakagami H, Nozaki K, Morishita R, Hashimoto N.

Neurosurgery. 2009 Feb;64(2):357-65; discussion 365-6. doi: 10.1227/01.NEU.0000336764.92606.1D.

PMID:
19190463
3.
5.

Simvastatin suppresses the progression of experimentally induced cerebral aneurysms in rats.

Aoki T, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N.

Stroke. 2008 Apr;39(4):1276-85. doi: 10.1161/STROKEAHA.107.503086. Epub 2008 Feb 28.

6.

NF-kappaB is a key mediator of cerebral aneurysm formation.

Aoki T, Kataoka H, Shimamura M, Nakagami H, Wakayama K, Moriwaki T, Ishibashi R, Nozaki K, Morishita R, Hashimoto N.

Circulation. 2007 Dec 11;116(24):2830-40. Epub 2007 Nov 19.

7.

Inhibition by a selective IkappaB kinase-2 inhibitor of interleukin-1-induced collagen degradation by corneal fibroblasts in three-dimensional culture.

Kondo Y, Fukuda K, Adachi T, Nishida T.

Invest Ophthalmol Vis Sci. 2008 Nov;49(11):4850-7. doi: 10.1167/iovs.08-1897. Epub 2008 Aug 1.

PMID:
18676628
8.

Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment.

Aoki T, Kataoka H, Nishimura M, Ishibashi R, Morishita R, Miyamoto S.

Neurosurgery. 2012 Jun;70(6):1534-43; discussion 1543. doi: 10.1227/NEU.0b013e318246a390. Erratum in: Neurosurgery. 2012 Aug;71(2):502.

PMID:
22186838
9.

Contribution of mast cells to cerebral aneurysm formation.

Ishibashi R, Aoki T, Nishimura M, Hashimoto N, Miyamoto S.

Curr Neurovasc Res. 2010 May;7(2):113-24.

PMID:
20334612
10.

Glutamine attenuates nitric oxide synthase expression and mitochondria membrane potential decrease in interleukin-1beta-activated rat hepatocytes.

Lu J, Wang XY, Tang WH.

Eur J Nutr. 2009 Sep;48(6):333-9. doi: 10.1007/s00394-009-0018-x. Epub 2009 Apr 4.

PMID:
19347386
11.

Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors.

Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M, Jo N, Oishi M, Kataoka K, Ohgi S, Ogihara T, Kaneda Y, Morishita R.

Circulation. 2004 Jan 6;109(1):132-8. Epub 2003 Dec 8.

13.
14.

Activation of ROS/NF-kappaB and Ca2+/CaM kinase II are necessary for VCAM-1 induction in IL-1beta-treated human tracheal smooth muscle cells.

Luo SF, Chang CC, Lee IT, Lee CW, Lin WN, Lin CC, Yang CM.

Toxicol Appl Pharmacol. 2009 May 15;237(1):8-21. doi: 10.1016/j.taap.2009.02.025. Epub 2009 Mar 10.

PMID:
19281832
15.

Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.

Kim KH, Lee ES, Cha SH, Park JH, Park JS, Chang YC, Park KK.

Exp Mol Pathol. 2009 Apr;86(2):114-20. doi: 10.1016/j.yexmp.2008.11.011. Epub 2008 Dec 11.

PMID:
19118545
16.

Inhibitory effects of epigallocatechin-3-O-gallate on serum-stimulated rat aortic smooth muscle cells via nuclear factor-kappaB down-modulation.

Han DW, Lim HR, Baek HS, Lee MH, Lee SJ, Hyon SH, Park JC.

Biochem Biophys Res Commun. 2006 Jun 23;345(1):148-55. Epub 2006 Apr 27.

PMID:
16677605
17.
18.

Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation.

Aoki T, Kataoka H, Ishibashi R, Nozaki K, Egashira K, Hashimoto N.

Stroke. 2009 Mar;40(3):942-51. doi: 10.1161/STROKEAHA.108.532556. Epub 2009 Jan 22.

19.
20.

Impaired progression of cerebral aneurysms in interleukin-1beta-deficient mice.

Moriwaki T, Takagi Y, Sadamasa N, Aoki T, Nozaki K, Hashimoto N.

Stroke. 2006 Mar;37(3):900-5. Epub 2006 Jan 26.

Items per page

Supplemental Content

Write to the Help Desk